Phase
Condition
Pancreatic Disorders
Pancreatitis
Pancreatic Cancer
Treatment
PTM-101
Clinical Study ID
Ages > 18 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Imaging consistent with primary borderline resectable or locally advanced PDAC. PDACmay be confirmed by histology/cytology either at study-mandated laparoscopy or byprior biopsy/cytology
Indicated for laparoscopy
No prior therapy of any kind for PDAC
Acceptable laboratory values
Eastern Cooperative Oncology Group (ECOG) performance status of 0 - 2
Ability to provide informed consent
No symptomatic pancreatitis
No other active medical issues which would confound interpretation of safetymonitoring, efficacy results or prevent the subject from study participation
Subjects with childbearing potential must agree to use adequate contraceptionthroughout study participation
Exclusion
Exclusion Criteria:
Active non-pancreatic cancer that currently requires treatment or is being treated;diagnosis of another malignancy within the past 2 years. This criterion excludes ahistory of carcinoma in situ of the cervix, superficial non-melanoma skin cancers,or superficial bladder cancer that has been adequately treated, or stage 1 prostatecancer that does not require treatment or requires only treatment with luteinizinghormone-releasing hormone agonists or antagonists if initiated at least 30 daysprior to screening). Other potentially indolent cancers may be considered.
Contraindications or allergies to paclitaxel, PLGA (poly(lactic-co-glycolic ) acid),or contraindications to implantation of PTM-101 or chemotherapies in protocol (e.g.,FOLFIRINOX, gemcitabine, nab-paclitaxel)
Known history of human immunodeficiency virus (HIV) or active viral hepatitis
Active ongoing infection or autoimmune disease which may preclude laparoscopy,placement of PTM-101, administration of chemotherapy or surgical resection ofpancreatic tumor
Inability to comply with activities and therapeutic interventions as outlined in theschedule of events
Currently enrolled in another investigational drug or device trial
Women who are pregnant or breastfeeding or who plan to become pregnant orbreastfeed; men who plan to donate sperm or conceive a child
Any other medical or surgical conditions, including prior abdominal surgery, thatwould preclude safe laparoscopy or implantation in the opinion of the investigator
Study Design
Study Description
Connect with a study center
Hoag Memorial Hospital Presbyterian
Newport Beach, California 92658
United StatesActive - Recruiting
Hoag Memorial Hospital Presbyterian
Newport Beach 5376890, California 5332921 92658
United StatesSite Not Available
Karmanos Cancer Institute
Detroit, Michigan 48201
United StatesActive - Recruiting
Karmanos Cancer Institute
Detroit 4990729, Michigan 5001836 48201
United StatesSite Not Available
Northwell Health Zuckerberg Cancer Center
Lake Success, New York 11042
United StatesActive - Recruiting
Northwell Health Zuckerberg Cancer Center
Lake Success 5123853, New York 5128638 11042
United StatesSite Not Available
University of Texas Southwestern Medical Center
Dallas, Texas 75390
United StatesActive - Recruiting
The University of Texas MD Anderson Cancer Center
Houston, Texas 77030
United StatesActive - Recruiting
University of Texas Southwestern Medical Center
Dallas 4684888, Texas 4736286 75390
United StatesSite Not Available
The University of Texas MD Anderson Cancer Center
Houston 4699066, Texas 4736286 77030
United StatesSite Not Available
Virginia Mason Medical Center
Seattle, Washington 98101
United StatesActive - Recruiting
Virginia Mason Medical Center
Seattle 5809844, Washington 5815135 98101
United StatesSite Not Available

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.